The author said they had told Egualia that generic and biosimilar medicines played a key role in widening access to treatment, supporting sustainable health systems and strengthening the EU’s security of supply. https://t.co/NSAboS2lZ6 #Salud #Medicamentos #AccesoMedicamentos #EU
The author said Europe needed more pharmaceutical manufacturing capacity at home. In a message for the opening of Sandoz’s new biosimilars site in Lendava, they said investments like the facility could improve access to affordable medicines, create skilled jobs and make supply chains more resilient. https://t.co/8oxlpbLp2I #Pharmaceuticals #Biosimilars #Healthcare #SI
🇪🇺 patients need timely access to affordable medicines. Good discussion with @medicinesforEU President Steffen Saltofte on how generics&biosimilars can contribute to a resilient healthcare system. Keeping manufacturing in 🇪🇺 is key - our policies must work together to support it https://t.co/EzCTL4BqhD #AffordableMedicines #Generics #HealthcareSystem #EU #EU
Generics and biosimilars are key to keeping medicines accessible & health systems sustainable. At @medicinesforEU Conference in Athens, I highlighted how #pharmareform, #CriticalMedicinesAct & #BiotechAct will strengthen affordability, supply resilience and 🇪🇺medicine security. https://t.co/cJW6Qhq6C3 #pharmareform #CriticalMedicinesAct #BiotechAct #EU
